世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

HIV診断薬市場


HIV Diagnostics Market

HIV診断薬市場。世界の産業分析2015-2021年および機会評価2022-2032年 FMIが発行したHIV診断薬に関する最新市場調査は、2015年から2021年までの世界の産業分析と2022年から2032年までの機会評価を提供しています... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Future Market Insights
フューチャーマーケットインサイツ
2022年10月5日 US$5,000
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
306 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

HIV診断薬市場。世界の産業分析2015-2021年および機会評価2022-2032年
FMIが発行したHIV診断薬に関する最新市場調査は、2015年から2021年までの世界の産業分析と2022年から2032年までの機会評価を提供しています。本調査では、最も重要な市場力学の包括的な評価を提供しています。過去と現在の成長パラメータについて徹底的な調査を行った後、市場の成長見通しを最大限の精度で得ています。

市場の細分化
HIV診断薬の世界市場は、市場のあらゆる側面をカバーし、読者に完全な市場情報を提示するため、詳細にセグメント化されています。

製品別 - 消耗品
- 機器
- ソフトウェア&サービス
検査タイプ別 - 抗体検査
- ウイルス負荷試験
- CD4検査
- その他
エンドユーザー別 - 診断検査機関
- 病院
- その他
地域別 - 北米
- ラテンアメリカ
- 欧州
- 中近東・アフリカ
- 東アジア
- 南アジア

レポートの章立て
エグゼクティブサマリー
HIV診断薬市場のエグゼクティブサマリーには、世界市場の展望、需要サイドの動向、供給サイドの動向、またHIV診断薬に関するFMI分析および推奨事項が含まれています。

第01章 市場の概要
本章では、HIV診断薬市場の詳細なセグメントと定義について説明し、HIV診断薬に関する基本的な情報を理解するのに役立てます。また、市場範囲、分類、制限など、HIV診断薬市場レポートの市場範囲を読者が理解するのに役立つハイライトです。
第02章 市場の背景
本章では、製品加工方法の概要、消費者の購買パターンや傾向、政策展開や規制シナリオなどの詳細な分析を行っています。また、マクロ経済要因の詳細な分析も含まれており、世界のGDP成長見通し、世界の産業付加価値、個人消費、支出、現代貿易の普及、消費者物価指数などのトピックをカバーしています。本章では、市場をより深く理解するために、予測要因 - 関連性と影響、バリューチェーン分析、市場ダイナミクス(推進要因、抑制要因、機会)についても取り上げています。
第03章 世界のHIV診断薬市場の需要分析2015-2021年および予測、2022-2032年
本章では、過去の市場価値(XX Bn米ドル)分析(2015-2021年)と現在および将来の市場価値(64億米ドル)および数量(7.9%)の予測(2022-2032年)を掲載します。予測は、前年比成長トレンド分析および絶対金額機会分析国に基づいています。
第04章 HIV診断薬の世界市場 - 価格設定分析
製品別に、地域別価格分析(USD/MT)、世界平均価格分析ベンチマーク、価格に影響を与える主な要因などの価格分析章を設けています。
第05章 HIV診断薬の世界市場分析2015-2021年および予測2022-2032年、製品別
製品別では、HIV診断薬市場は消耗品、機器、ソフトウェア、サービスに区分されます。また、By Productに基づく市場魅力度分析も行っています。また、上記のBy Productに基づく価値予測やYoY成長率比較も提供します。
第06章:HIV診断薬の世界市場分析2015-2021年および予測2022-2032年:検査タイプ別
HIV診断薬市場は、検査タイプ別に、抗体検査、ウイルス負荷検査、CD4検査、その他に区分されます。また、検査タイプ別の市場魅力度分析も行っています。また、上記のBy Test Typeに基づく価値予測やYo-Y成長率比較も提供します。
第07章:HIV診断薬の世界市場分析(2015-2021年)および予測(2022-2032年):エンドユース別
エンドユーザー別に、HIV診断薬市場は診断ラボ、病院、その他に区分されます。また、エンドユース別に市場の魅力度分析も行っています。また、上記のBy End Useに基づく価値予測やYoY成長率比較も提供します。
第08章:HIV診断薬の世界市場分析2015-2021年および予測2022-2032年(地域別
HIV診断薬市場は、地域別に北米、中南米、ヨーロッパ、中東・アフリカ、東アジア、南アジア、オセアニアに区分されます。また、地域別の市場魅力度分析も行っています。また、上記地域別の金額予測や前年比成長率比較も掲載しています。
第09章 北米HIV診断薬市場の分析2015-2021年および予測2022-2032年
本章では、北米地域におけるHIV診断薬の成長について、米国とカナダを含む国別の評価とともに詳細に分析します。また、北米地域の異なるセグメントや国に基づいた地域動向、規制、市場成長もご覧いただけます。
第10章 ラテンアメリカのHIV診断薬市場分析2015-2021年および予測2022-2032年
本章では、中南米地域におけるHIV診断薬の成長について、ブラジル、メキシコ、チリ、アルゼンチン、ペルー、その他の中南米を含む国別の評価とともに、詳細な分析を掲載しています。読者は、ラテンアメリカ地域におけるHIV診断薬市場の成長に影響を与える価格分析や地域動向などのいくつかの要因に関する詳細な情報を見つけることができます。
第11章- 欧州HIV診断薬市場の分析2015-2021年および予測2022-2032年
本章では、ドイツ、イタリア、フランス、イギリス、スペイン、ロシア、北欧、ベネルクス、その他のヨーロッパを含む国別評価とともに、ヨーロッパ地域におけるHIV診断薬の成長に関する詳細な分析が含まれています。読者は、地域市場におけるHIV診断薬市場の成長に影響を与える価格分析や地域動向などのいくつかの要因についての詳細情報を見つけることができます。
第12章 東アジアのHIV診断薬市場分析2015-2021年および予測2022-2032年
本章では、東アジア地域におけるHIV診断薬の成長について、中国、日本、韓国を含む国別の評価とともに詳細に分析します。読者は、地域市場におけるHIV診断薬市場の成長に影響を与える価格分析および地域動向などのいくつかの要因に関する詳細な情報を得ることができます。
第13章 南アジアのHIV診断薬市場分析2015-2021年および予測2022-2032年
本章では、南アジア地域におけるHIV診断薬の成長について、インド、インドネシア、マレーシア、タイ、その他の南アジア地域を含む国別の評価とともに詳細に分析します。読者は、地域市場におけるHIV診断薬市場の成長に影響を与える価格分析や地域動向などのいくつかの要因に関する詳細な情報を見つけることができます。
第14章 中東およびアフリカのHIV診断薬市場分析2015-2021年および予測2022-2032年
本章では、MEA地域におけるHIV診断薬の成長について、GCC諸国、南アフリカ、北アフリカ、トルコ、その他のMEAを含む国別の評価とともに詳細に分析します。読者は、地域市場におけるHIV診断薬市場の成長に影響を与える価格分析や地域動向など、いくつかの要因に関する詳細な情報を得ることができます。
第15章 主要国のHIV診断薬市場分析2015-2021年および予測2022-2032年
本章では、世界の主要国においてHIV診断薬市場がどのように成長すると予想されるかについての洞察を提供します。
第16章 市場構造分析-グローバルアセスメント
本章では、企業ダッシュボード、企業の階層別産業構造分析、2022E、トッププレイヤーの企業シェア分析、2022E、競合ベンチマーキング-マトリクスを掲載しています。
第17章 競合のディープダイブ(暫定リスト)
本章では、レポートで調査している企業の会社概要、企業の製品ポートフォリオ、市場セグメント別の収益性、売上高フットプリント、SWOT分析、戦略概要などを紹介しています。レポート中で紹介されている市場プレイヤーは、Siemens Healthineers,F. Hoffmann-La Roche Ltd.などです。Hoffmann-La Roche Ltd、Abbott Laboratories、Danaher Corporation、Thermo-Fisher Scientific Inc.など。
第18章 前提条件と頭字語
この章では、HIV Diagnosticsレポートに含まれる情報や統計の根拠となる頭字語や仮定をリストアップしています。
第19章 - 調査方法論
この章では、HIV診断薬市場に関する様々な結論や重要な定性的・定量的情報を得るために実施した調査方法について読者に理解していただきます。

ページTOPに戻る


目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on HIV Diagnostics

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. HIV Diagnostics Market, by Key Countries

    4.2. HIV Diagnostics Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. HIV Diagnostics Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global HIV Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global HIV Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product , 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product , 2022-2032

        8.3.1. Consumables

        8.3.2. Instruments

        8.3.3. Software & Services

    8.4. Market Attractiveness Analysis By Product

9. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2022-2032

        9.3.1. Antibody Tests

        9.3.2. Viral Load Tests

        9.3.3. CD4 Tests

        9.3.4. Others

    9.4. Market Attractiveness Analysis By Test Type

10. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032

        10.3.1. Diagnostic Laboratories

        10.3.2. Hospitals

        10.3.3. Others

    10.4. Market Attractiveness Analysis By End User

11. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Product

        12.4.3. By End User

        12.4.4. By Test Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product

        12.5.3. By End User

        12.5.4. By Test Type

13. Latin America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Product

        13.4.3. By End User

        13.4.4. By Test Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

        13.5.3. By End User

        13.5.4. By Test Type

14. Europe HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Product

        14.4.3. By End User

        14.4.4. By Test Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By End User

        14.5.4. By Test Type

15. Asia Pacific HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Product

        15.4.3. By End User

        15.4.4. By Test Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By End User

        15.5.4. By Test Type

16. Middle East and Africa HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Product

        16.4.3. By End User

        16.4.4. By Test Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By End User

        16.5.4. By Test Type

17. Key Countries HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US HIV Diagnostics Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Product

            17.2.2.2. By End User

            17.2.2.3. By Test Type

    17.3. Canada HIV Diagnostics Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Product

            17.3.2.2. By End User

            17.3.2.3. By Test Type

    17.4. Mexico HIV Diagnostics Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Product

            17.4.2.2. By End User

            17.4.2.3. By Test Type

    17.5. Brazil HIV Diagnostics Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Product

            17.5.2.2. By End User

            17.5.2.3. By Test Type

    17.6. Germany HIV Diagnostics Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Product

            17.6.2.2. By End User

            17.6.2.3. By Test Type

    17.7. France HIV Diagnostics Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Product

            17.7.2.2. By End User

            17.7.2.3. By Test Type

    17.8. Italy HIV Diagnostics Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Product

            17.8.2.2. By End User

            17.8.2.3. By Test Type

    17.9. BENELUX HIV Diagnostics Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Product

            17.9.2.2. By End User

            17.9.2.3. By Test Type

    17.10. UK HIV Diagnostics Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Product

            17.10.2.2. By End User

            17.10.2.3. By Test Type

    17.11. Nordic Countries HIV Diagnostics Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Product

            17.11.2.2. By End User

            17.11.2.3. By Test Type

    17.12. China HIV Diagnostics Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Product

            17.12.2.2. By End User

            17.12.2.3. By Test Type

    17.13. Japan HIV Diagnostics Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Product

            17.13.2.2. By End User

            17.13.2.3. By Test Type

    17.14. South Korea HIV Diagnostics Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Product

            17.14.2.2. By End User

            17.14.2.3. By Test Type

    17.15. GCC Countries HIV Diagnostics Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Product

            17.15.2.2. By End User

            17.15.2.3. By Test Type

    17.16. South Africa HIV Diagnostics Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Product

            17.16.2.2. By End User

            17.16.2.3. By Test Type

    17.17. Turkey HIV Diagnostics Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Product

            17.17.2.2. By End User

            17.17.2.3. By Test Type

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Siemens Healthineers

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. F. Hoffmann-La Roche Ltd

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Abbott Laboratories

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Danaher Corporation

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Thermo-Fisher Scientific Inc

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Merck KGaA

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Becton, Dickinson & Company

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Hologic Inc

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Bio-Rad Laboratories

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Alere Inc

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

 

ページTOPに戻る


 

Summary

HIV Diagnostics Market: Global Industry Analysis 2015-2021 and Opportunity Assessment 2022-2032
A recent market study published by FMI on HIV Diagnostics offers a global industry analysis for 2015-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation
The global HIV Diagnostics Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Product • Consumables
• Instruments
• Software & Services
By Test Type • Antibody Tests
• Viral Load Tests
• CD4 Tests
• Others
By End Use • Diagnostic Laboratories
• Hospitals
• Others
By Region • North America
• Latin America
• Europe
• Middle east and Africa
• East Asia
• South Asia

Report Chapters
Executive Summary
The executive summary of the HIV Diagnostics Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of HIV Diagnostics.

Chapter 01 – Market Overview
Readers can find the detailed segmentation and definition of the HIV Diagnostics Market in this chapter, which will help to understand basic information about HIV Diagnostics. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of HIV Diagnostics Market report.
Chapter 02 – Market Background
This chapter includes detailed analysis of the product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 – Global HIV Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032
The chapter include historical market value (US$ XX Bn) analysis (2015-2021) and current and future market value (US$ 6.4 Bn) and volume (7.9%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 – Global HIV Diagnostics Market - Pricing Analysis
Based on By Product, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 – Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product
Based on By Product, HIV Diagnostics Market is segmented into Consumables,Instruments,Software & Services. This section also offers market attractiveness analysis based on By Product. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Product.
Chapter 06 – Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type
Based on By Test Type, HIV Diagnostics Market is segmented into Antibody Tests,Viral Load Tests,CD4 Tests,Others. This section also offers market attractiveness analysis based on By Test Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Test Type.
Chapter 07 – Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End Use
Based on By End Use, HIV Diagnostics Market is segmented into Diagnostic Laboratories,Hospitals,Others. This section also offers market attractiveness analysis based on By End Use. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End Use.
Chapter 08 – Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region
Based on By Region, HIV Diagnostics Market is segmented into North America,Latin America,Europe,Middle east and Africa,East Asia,South Asia,Oceania. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 09 – North America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the HIV Diagnostics in the North American Region, along with a country-wise assessment that includes the US and Canada. Readers can also find Regional trends, regulations, and market growth based on different segment and countries in the North America Region.
Chapter 10 – Latin America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of HIV Diagnostics in the Latin America Region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the HIV Diagnostics Market in the Latin America Region.
Chapter 11– Europe HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of HIV Diagnostics in the European Region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the HIV Diagnostics Market in the Regional market.
Chapter 12 – East Asia HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of HIV Diagnostics in the East Asia Region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the HIV Diagnostics Market in the Regional market.
Chapter 13 – South Asia HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of HIV Diagnostics in the South Asia Region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the HIV Diagnostics Market in the Regional market.
Chapter 14 - Middle East and Africa HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of HIV Diagnostics in the MEA Region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the HIV Diagnostics Market in the Regional market.
Chapter 15 - Key Countries HIV Diagnostics Market Analysis 2015–2021 and Forecast 2022–2032
This chapter offers insights into how the HIV Diagnostics Market is expected to grow in major countries globally.
Chapter 16 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 17 - Competition Deep Dive (Tentative List)
This chapter includes company overview, product portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Siemens Healthineers,F. Hoffmann-La Roche Ltd,Abbott Laboratories,Danaher Corporation,Thermo-Fisher Scientific Inc.
Chapter 18 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the HIV Diagnostics report.
Chapter 19 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on HIV Diagnostics Market.



ページTOPに戻る


Table of Contents

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on HIV Diagnostics

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. HIV Diagnostics Market, by Key Countries

    4.2. HIV Diagnostics Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. HIV Diagnostics Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global HIV Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global HIV Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product , 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product , 2022-2032

        8.3.1. Consumables

        8.3.2. Instruments

        8.3.3. Software & Services

    8.4. Market Attractiveness Analysis By Product

9. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2022-2032

        9.3.1. Antibody Tests

        9.3.2. Viral Load Tests

        9.3.3. CD4 Tests

        9.3.4. Others

    9.4. Market Attractiveness Analysis By Test Type

10. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032

        10.3.1. Diagnostic Laboratories

        10.3.2. Hospitals

        10.3.3. Others

    10.4. Market Attractiveness Analysis By End User

11. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Product

        12.4.3. By End User

        12.4.4. By Test Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product

        12.5.3. By End User

        12.5.4. By Test Type

13. Latin America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Product

        13.4.3. By End User

        13.4.4. By Test Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

        13.5.3. By End User

        13.5.4. By Test Type

14. Europe HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Product

        14.4.3. By End User

        14.4.4. By Test Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By End User

        14.5.4. By Test Type

15. Asia Pacific HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Product

        15.4.3. By End User

        15.4.4. By Test Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By End User

        15.5.4. By Test Type

16. Middle East and Africa HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Product

        16.4.3. By End User

        16.4.4. By Test Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By End User

        16.5.4. By Test Type

17. Key Countries HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US HIV Diagnostics Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Product

            17.2.2.2. By End User

            17.2.2.3. By Test Type

    17.3. Canada HIV Diagnostics Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Product

            17.3.2.2. By End User

            17.3.2.3. By Test Type

    17.4. Mexico HIV Diagnostics Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Product

            17.4.2.2. By End User

            17.4.2.3. By Test Type

    17.5. Brazil HIV Diagnostics Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Product

            17.5.2.2. By End User

            17.5.2.3. By Test Type

    17.6. Germany HIV Diagnostics Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Product

            17.6.2.2. By End User

            17.6.2.3. By Test Type

    17.7. France HIV Diagnostics Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Product

            17.7.2.2. By End User

            17.7.2.3. By Test Type

    17.8. Italy HIV Diagnostics Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Product

            17.8.2.2. By End User

            17.8.2.3. By Test Type

    17.9. BENELUX HIV Diagnostics Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Product

            17.9.2.2. By End User

            17.9.2.3. By Test Type

    17.10. UK HIV Diagnostics Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Product

            17.10.2.2. By End User

            17.10.2.3. By Test Type

    17.11. Nordic Countries HIV Diagnostics Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Product

            17.11.2.2. By End User

            17.11.2.3. By Test Type

    17.12. China HIV Diagnostics Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Product

            17.12.2.2. By End User

            17.12.2.3. By Test Type

    17.13. Japan HIV Diagnostics Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Product

            17.13.2.2. By End User

            17.13.2.3. By Test Type

    17.14. South Korea HIV Diagnostics Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Product

            17.14.2.2. By End User

            17.14.2.3. By Test Type

    17.15. GCC Countries HIV Diagnostics Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Product

            17.15.2.2. By End User

            17.15.2.3. By Test Type

    17.16. South Africa HIV Diagnostics Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Product

            17.16.2.2. By End User

            17.16.2.3. By Test Type

    17.17. Turkey HIV Diagnostics Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Product

            17.17.2.2. By End User

            17.17.2.3. By Test Type

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Siemens Healthineers

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. F. Hoffmann-La Roche Ltd

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Abbott Laboratories

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Danaher Corporation

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Thermo-Fisher Scientific Inc

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Merck KGaA

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Becton, Dickinson & Company

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Hologic Inc

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Bio-Rad Laboratories

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Alere Inc

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(診断薬)の最新刊レポート

Future Market Insights社の診断薬分野での最新刊レポート


よくあるご質問


Future Market Insights社はどのような調査会社ですか?


Future Market Insights(FMI)は世界の広範な地域および産業を対象にした調査レポートを出版しています。  弊社ウェブサイトに掲載のないタイトルも全てお取り扱い可能ですので... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る